157 related articles for article (PubMed ID: 101159)
1. Studies on the effect of tolbutamide, glibenclamide, HB 699, and glucose on serum insulin and blood glucose in gastro-enterectomized dogs.
Bickel M; Geisen K; Schleyerbach R
Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):118-38. PubMed ID: 101159
[TBL] [Abstract][Full Text] [Related]
2. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
3. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
4. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
5. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
Loubatières A; Ribes G; Mariani MM; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
[No Abstract] [Full Text] [Related]
6. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
[No Abstract] [Full Text] [Related]
7. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
Raptis SA; Hatziagelaki E; Dimitriadis G; Draeger KE; Pfeiffer C; Raptis AE
Exp Clin Endocrinol Diabetes; 1999; 107(6):350-5. PubMed ID: 10543411
[TBL] [Abstract][Full Text] [Related]
8. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin].
Beyer J; Cordes U; Sell G; Krall H; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247
[No Abstract] [Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
10. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
[No Abstract] [Full Text] [Related]
11. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
Katsumata K; Katsumata Y
Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
[No Abstract] [Full Text] [Related]
12. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes.
Müller G; Geisen K
Horm Metab Res; 1996 Sep; 28(9):469-87. PubMed ID: 8911985
[TBL] [Abstract][Full Text] [Related]
13. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
[TBL] [Abstract][Full Text] [Related]
14. Special pharmacology of the new sulfonylurea glimepiride.
Geisen K
Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic and acute treatment with sulfonylureas on plasma insulin and glucose levels in the rat.
Codina J; Lasuncion MA; Herrera E
Diabete Metab; 1978 Mar; 4(1):47-52. PubMed ID: 97105
[No Abstract] [Full Text] [Related]
16. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
Rizzi G; Isaia GC
Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
[No Abstract] [Full Text] [Related]
17. Glipizide: experimental study and comparison with other sulfonylureas.
Loubatieres-Mariani MM
Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
[No Abstract] [Full Text] [Related]
18. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].
Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967
[No Abstract] [Full Text] [Related]
19. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
[No Abstract] [Full Text] [Related]
20. Effect of PGE2 on sulfonylurea induced insulin release.
Villar A; Ivorra MD; Anselmi E
J Physiol (Paris); 1987; 82(1):12-7. PubMed ID: 3123643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
